Assessing the Implementation & Feasibility of the SMART-MR

Status Completed

Clinical Trial Summary

The objective of the proposed pilot study is to assess the feasibility and implementation of the SMART-MR program, an integration of stress management, general resilience, and moral resilience skills, with frontline staff who provide direct patient care at The Ottawa Hospital (TOH).

Clinical Trial Description

Many of the sources of stress facing healthcare workers during the COVID-19 pandemic involve difficult ethical trade-offs that give rise to moral distress. Moral distress has personal consequences for healthcare workers, notably for their mental health, and wider consequences for the organization and health system as a whole as it negatively affects quality of care, patient satisfaction, and the recruitment, retention and satisfaction of staff. Moral resilience refers to the capacity of an individual to sustain or restore their integrity in response to moral adversity and has been raised as a potential way to mitigate moral distress. The Stress Management and Resilience Training (SMART) program is one of the few evidence-based interventions designed to build resilience in healthcare workers. The SMART program is a brief, neuroscience-based intervention, typically delivered in a single 90-minute session. The structured program teaches self-care skills by developing intentional attention and the ability to reframe potentially stressful situations more quickly. Recently, a modified version of the existing SMART program, SMART-Moral Resilience (SMART-MR), has been developed with an additional focus on reducing moral distress and building moral resilience for healthcare workers. The synergy of general resilience strategies with focus on the moral/ethical dimensions of clinical practice offer clinicians specific skills to address ethical challenges. We believe implementing the SMART-MR program with frontline staff during the COVID-19 pandemic is warranted. Therefore, we plan to pilot this innovative intervention at TOH to assess its feasibility and implementation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05122910
Study type	Interventional
Source	University of Ottawa
Contact
Status	Completed
Phase	N/A
Start date	July 15, 2022
Completion date	December 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05514093` - Beyond Silence: Advancing E-mental Health Solutions to Support Canadian Healthcare Workers
Completed	`NCT04261751` - Moral Injury Symptom Scale/Moral Injury Outcome Scale
Completed	`NCT05001542` - Digital Interventions for Detection and Reduction of Moral Distress	N/A
Active, not recruiting	`NCT05163496` - Frontline Clinician Psilocybin Study	Phase 3
Completed	`NCT03906240` - Pilot Study Testing a Web-Based Moral Elevation Intervention for Veterans With PTSD and Moral Injury	N/A
Completed	`NCT03056157` - Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure	N/A
Not yet recruiting	`NCT05732155` - Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.	Phase 2
Completed	`NCT03681288` - Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD	N/A
Recruiting	`NCT04626050` - General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19	N/A
Active, not recruiting	`NCT05635448` - Better Together Physician Coaching to Mitigate Burnout Amongst Clinicians	N/A
Completed	`NCT05550753` - Better Together Physician Coaching to Mitigate Burnout in Male-Identifying Trainees	N/A
Recruiting	`NCT06394284` - Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury	Phase 3
Recruiting	`NCT05020587` - Consulting After Combat: Interviewing Veterans to Develop a Therapy to Restore Functioning and Reintegration After Moral Injury Events	Early Phase 1
Completed	`NCT05280964` - Better Together: an Online Physician Coaching Program for Medical Trainees	N/A
Active, not recruiting	`NCT03764033` - A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury	N/A
Active, not recruiting	`NCT03760731` - Thriving in the Midst of Moral Pain: The Acceptability and Feasibility of Acceptance and Commitment Therapy for Moral Injury (ACT-MI) Among Warzone Veterans	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessing the Implementation and Feasibility of the SMART-MR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms